scispace - formally typeset
J

James S. Allan

Researcher at Harvard University

Publications -  138
Citations -  8778

James S. Allan is an academic researcher from Harvard University. The author has contributed to research in topics: Miniature swine & Transplantation. The author has an hindex of 39, co-authored 138 publications receiving 8279 citations. Previous affiliations of James S. Allan include Macquarie University & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Stability, Precision, and Near-24-Hour Period of the Human Circadian Pacemaker

TL;DR: In this article, the intrinsic period of the human circadian pacemaker averages 24.18 hours in both age groups, with a tight distribution consistent with other species, with important implications for understanding the pathophysiology of disrupted sleep in older people.
Journal ArticleDOI

Bright light induction of strong (type 0) resetting of the human circadian pacemaker.

TL;DR: The data indicate that the sensitivity of the human circadian pacemaker to light is far greater than previously recognized and have important implications for the therapeutic use of light in the management of disorders of circadian regulation.
Journal ArticleDOI

Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle.

TL;DR: Exposure to bright light can indeed reset the human circadian pacemaker, which controls daily variations in physiologic, behavioral, and cognitive function, as indicated by recordings of body temperature and cortisol secretion.
Journal ArticleDOI

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III

TL;DR: It is hypothesized that gp160 and gp120 represent the major species of virus-encoded envelope gene products for HTLV-III.
Journal ArticleDOI

Serological evidence for virus related to simian t-lymphotropic retrovirus iii in residents of west africa

TL;DR: Serological evidence is presented here suggesting that a virus closely related to simian T-lymphotropic virus type III (STLV-III) infects man in Senegal, west Africa, a region where AIDS or AIDS-related diseases have not yet been observed.